Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy | 26 | 2024 | 2213 | 2.050 |
Why?
|
| Premature Birth | 5 | 2024 | 108 | 1.710 |
Why?
|
| Placenta Diseases | 4 | 2021 | 8 | 1.710 |
Why?
|
| Lead | 3 | 2024 | 40 | 1.670 |
Why?
|
| Placenta | 5 | 2021 | 55 | 1.660 |
Why?
|
| Pre-Eclampsia | 4 | 2022 | 70 | 1.540 |
Why?
|
| Infertility, Female | 8 | 2021 | 44 | 1.530 |
Why?
|
| Mothers | 4 | 2023 | 257 | 1.450 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2021 | 13 | 1.430 |
Why?
|
| Stillbirth | 2 | 2023 | 17 | 1.410 |
Why?
|
| Ischemia | 3 | 2020 | 199 | 1.290 |
Why?
|
| Sex Offenses | 4 | 2024 | 46 | 1.270 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2021 | 35 | 1.220 |
Why?
|
| Fertilization in Vitro | 4 | 2021 | 83 | 1.160 |
Why?
|
| Oocyte Donation | 4 | 2019 | 6 | 1.120 |
Why?
|
| Aneuploidy | 2 | 2023 | 40 | 1.050 |
Why?
|
| Obstetrics | 3 | 2024 | 80 | 1.020 |
Why?
|
| Transcription Factor TFIIIA | 1 | 2025 | 7 | 0.970 |
Why?
|
| Golgi Apparatus | 1 | 2025 | 63 | 0.950 |
Why?
|
| Female | 38 | 2024 | 30724 | 0.940 |
Why?
|
| Counseling | 2 | 2024 | 350 | 0.930 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2025 | 90 | 0.930 |
Why?
|
| Lead Poisoning | 1 | 2024 | 10 | 0.930 |
Why?
|
| Infertility | 3 | 2020 | 30 | 0.920 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2025 | 80 | 0.910 |
Why?
|
| Cell Movement | 3 | 2025 | 428 | 0.910 |
Why?
|
| Prenatal Diagnosis | 1 | 2023 | 38 | 0.850 |
Why?
|
| Prenatal Care | 3 | 2022 | 170 | 0.830 |
Why?
|
| Focus Groups | 1 | 2024 | 288 | 0.820 |
Why?
|
| Genetic Testing | 1 | 2023 | 126 | 0.810 |
Why?
|
| Embryo Transfer | 2 | 2021 | 23 | 0.810 |
Why?
|
| Cesarean Section | 4 | 2024 | 95 | 0.790 |
Why?
|
| Reproductive Techniques, Assisted | 4 | 2017 | 31 | 0.780 |
Why?
|
| Humans | 48 | 2025 | 59389 | 0.760 |
Why?
|
| Maternal Health Services | 1 | 2022 | 63 | 0.760 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2021 | 27 | 0.760 |
Why?
|
| Breast Feeding | 1 | 2023 | 144 | 0.730 |
Why?
|
| Emotions | 1 | 2023 | 215 | 0.720 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2021 | 39 | 0.710 |
Why?
|
| Rape | 1 | 2020 | 15 | 0.710 |
Why?
|
| Placental Insufficiency | 1 | 2020 | 1 | 0.700 |
Why?
|
| Placental Circulation | 1 | 2020 | 1 | 0.700 |
Why?
|
| Adult | 23 | 2024 | 15683 | 0.680 |
Why?
|
| Depression, Postpartum | 1 | 2022 | 131 | 0.650 |
Why?
|
| Bone and Bones | 1 | 2020 | 137 | 0.640 |
Why?
|
| Pancreatic Neoplasms | 5 | 2023 | 331 | 0.630 |
Why?
|
| Communication | 1 | 2023 | 546 | 0.610 |
Why?
|
| Pregnancy Complications | 3 | 2024 | 364 | 0.610 |
Why?
|
| Risk Factors | 9 | 2022 | 4986 | 0.570 |
Why?
|
| Community Health Centers | 2 | 2017 | 89 | 0.560 |
Why?
|
| Retrospective Studies | 10 | 2024 | 6071 | 0.550 |
Why?
|
| Gingival Neoplasms | 1 | 2016 | 2 | 0.550 |
Why?
|
| Resilience, Psychological | 1 | 2017 | 55 | 0.540 |
Why?
|
| Tissue Donors | 2 | 2017 | 143 | 0.540 |
Why?
|
| Infant, Newborn | 5 | 2022 | 1284 | 0.530 |
Why?
|
| Infant Mortality | 1 | 2016 | 19 | 0.530 |
Why?
|
| Infant | 4 | 2023 | 1492 | 0.530 |
Why?
|
| Hypertension | 1 | 2022 | 570 | 0.520 |
Why?
|
| Self Concept | 2 | 2017 | 105 | 0.520 |
Why?
|
| Depression | 2 | 2022 | 829 | 0.480 |
Why?
|
| Family Planning Services | 1 | 2014 | 22 | 0.450 |
Why?
|
| Gestational Age | 4 | 2024 | 178 | 0.440 |
Why?
|
| Contraception Behavior | 1 | 2014 | 35 | 0.440 |
Why?
|
| Students | 4 | 2024 | 202 | 0.430 |
Why?
|
| Tissue and Organ Procurement | 1 | 2013 | 37 | 0.430 |
Why?
|
| Botswana | 4 | 2021 | 4 | 0.410 |
Why?
|
| Attitude to Health | 2 | 2014 | 279 | 0.410 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2023 | 106 | 0.400 |
Why?
|
| Stress, Psychological | 4 | 2017 | 442 | 0.390 |
Why?
|
| Progesterone | 2 | 2024 | 158 | 0.380 |
Why?
|
| Sperm Banks | 1 | 2011 | 2 | 0.380 |
Why?
|
| Qualitative Research | 3 | 2024 | 619 | 0.370 |
Why?
|
| Spermatozoa | 1 | 2013 | 253 | 0.370 |
Why?
|
| Disclosure | 1 | 2011 | 51 | 0.370 |
Why?
|
| Policy | 1 | 2011 | 48 | 0.360 |
Why?
|
| Placenta Growth Factor | 2 | 2021 | 15 | 0.360 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2021 | 20 | 0.360 |
Why?
|
| Placenta Accreta | 2 | 2021 | 2 | 0.360 |
Why?
|
| Actinin | 2 | 2021 | 9 | 0.360 |
Why?
|
| Ambulatory Care Facilities | 1 | 2011 | 101 | 0.360 |
Why?
|
| Fetal Death | 2 | 2020 | 12 | 0.330 |
Why?
|
| Live Birth | 2 | 2020 | 20 | 0.330 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 725 | 0.320 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2008 | 6 | 0.310 |
Why?
|
| Human papillomavirus 16 | 1 | 2008 | 17 | 0.310 |
Why?
|
| Virus Attachment | 1 | 2008 | 18 | 0.310 |
Why?
|
| Parturition | 2 | 2022 | 52 | 0.310 |
Why?
|
| Universities | 4 | 2024 | 144 | 0.310 |
Why?
|
| Vagina | 1 | 2008 | 79 | 0.300 |
Why?
|
| Mass Screening | 2 | 2024 | 648 | 0.290 |
Why?
|
| Anxiety | 2 | 2023 | 387 | 0.290 |
Why?
|
| Papillomavirus Infections | 1 | 2008 | 120 | 0.270 |
Why?
|
| Young Adult | 6 | 2024 | 4272 | 0.260 |
Why?
|
| Delivery, Obstetric | 2 | 2016 | 51 | 0.260 |
Why?
|
| Fetal Viability | 1 | 2024 | 3 | 0.230 |
Why?
|
| Membrane Transport Proteins | 1 | 2025 | 123 | 0.230 |
Why?
|
| Cerclage, Cervical | 1 | 2024 | 4 | 0.230 |
Why?
|
| Genome, Chloroplast | 1 | 2024 | 1 | 0.230 |
Why?
|
| Diatoms | 1 | 2024 | 2 | 0.230 |
Why?
|
| Progestins | 1 | 2024 | 29 | 0.230 |
Why?
|
| Genome, Mitochondrial | 1 | 2024 | 8 | 0.220 |
Why?
|
| Polyphenols | 1 | 2024 | 55 | 0.220 |
Why?
|
| Cervix Uteri | 2 | 2024 | 56 | 0.220 |
Why?
|
| Lysosomes | 2 | 2023 | 160 | 0.220 |
Why?
|
| HeLa Cells | 1 | 2025 | 526 | 0.220 |
Why?
|
| Cross-Sectional Studies | 5 | 2020 | 2380 | 0.210 |
Why?
|
| Gravidity | 2 | 2021 | 12 | 0.210 |
Why?
|
| Obstetric Labor, Premature | 2 | 2020 | 31 | 0.210 |
Why?
|
| Fertility | 2 | 2020 | 78 | 0.210 |
Why?
|
| Pregnancy Rate | 2 | 2021 | 29 | 0.200 |
Why?
|
| Phosphorylation | 1 | 2025 | 883 | 0.200 |
Why?
|
| Cell Cycle Proteins | 1 | 2025 | 384 | 0.200 |
Why?
|
| Gynecology | 2 | 2021 | 50 | 0.200 |
Why?
|
| Cohort Studies | 3 | 2023 | 2375 | 0.200 |
Why?
|
| Birth Weight | 1 | 2022 | 81 | 0.200 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2022 | 22 | 0.200 |
Why?
|
| Prospective Studies | 3 | 2020 | 3067 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2022 | 1051 | 0.190 |
Why?
|
| United States | 9 | 2021 | 7426 | 0.190 |
Why?
|
| Male | 9 | 2024 | 27747 | 0.190 |
Why?
|
| Pinocytosis | 1 | 2021 | 4 | 0.190 |
Why?
|
| Matrix Metalloproteinases | 1 | 2021 | 16 | 0.180 |
Why?
|
| Ovulation Induction | 1 | 2021 | 12 | 0.180 |
Why?
|
| Illinois | 1 | 2020 | 12 | 0.180 |
Why?
|
| Stromal Cells | 1 | 2021 | 65 | 0.180 |
Why?
|
| Sterol Esterase | 1 | 2020 | 6 | 0.180 |
Why?
|
| Lipid Droplets | 1 | 2020 | 31 | 0.170 |
Why?
|
| Fetal Growth Retardation | 1 | 2020 | 14 | 0.170 |
Why?
|
| Dynamin II | 1 | 2020 | 1 | 0.170 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 132 | 0.170 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 163 | 0.170 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 551 | 0.170 |
Why?
|
| Surveys and Questionnaires | 6 | 2022 | 2516 | 0.170 |
Why?
|
| Postpartum Period | 1 | 2022 | 187 | 0.170 |
Why?
|
| Curriculum | 2 | 2024 | 560 | 0.160 |
Why?
|
| Recurrence | 1 | 2021 | 602 | 0.160 |
Why?
|
| Hepatocytes | 1 | 2020 | 196 | 0.160 |
Why?
|
| Freezing | 1 | 2019 | 18 | 0.160 |
Why?
|
| Cryopreservation | 1 | 2019 | 27 | 0.160 |
Why?
|
| Blastocyst | 1 | 2019 | 70 | 0.150 |
Why?
|
| Health Equity | 1 | 2019 | 42 | 0.150 |
Why?
|
| Parity | 3 | 2022 | 70 | 0.150 |
Why?
|
| Autophagy | 1 | 2020 | 213 | 0.150 |
Why?
|
| Maternal-Child Health Centers | 1 | 2017 | 3 | 0.150 |
Why?
|
| Surrogate Mothers | 1 | 2017 | 1 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2011 | 454 | 0.140 |
Why?
|
| Gingiva | 1 | 2016 | 8 | 0.140 |
Why?
|
| Incidence | 1 | 2020 | 1238 | 0.130 |
Why?
|
| Urban Population | 1 | 2017 | 180 | 0.130 |
Why?
|
| Labor, Induced | 1 | 2016 | 25 | 0.130 |
Why?
|
| Contraception | 2 | 2014 | 67 | 0.130 |
Why?
|
| Labor, Obstetric | 1 | 2016 | 38 | 0.120 |
Why?
|
| Social Support | 2 | 2016 | 355 | 0.120 |
Why?
|
| Self Report | 1 | 2017 | 359 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2017 | 279 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2017 | 914 | 0.110 |
Why?
|
| Sex Education | 1 | 2014 | 25 | 0.110 |
Why?
|
| Pregnancy in Adolescence | 1 | 2014 | 23 | 0.110 |
Why?
|
| Boston | 1 | 2014 | 247 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2020 | 1925 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2021 | 5281 | 0.100 |
Why?
|
| HIV Infections | 1 | 2020 | 913 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 415 | 0.100 |
Why?
|
| Prevalence | 1 | 2016 | 1253 | 0.100 |
Why?
|
| Cervical Length Measurement | 2 | 2024 | 6 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 1368 | 0.100 |
Why?
|
| Child | 1 | 2022 | 4189 | 0.100 |
Why?
|
| Physicians | 1 | 2017 | 440 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2023 | 55 | 0.100 |
Why?
|
| Cell Line | 4 | 2021 | 1983 | 0.100 |
Why?
|
| Family | 1 | 2013 | 229 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2019 | 747 | 0.090 |
Why?
|
| Reproductive History | 1 | 2011 | 15 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1479 | 0.090 |
Why?
|
| Adolescent | 3 | 2024 | 5838 | 0.090 |
Why?
|
| Religion and Medicine | 1 | 2010 | 17 | 0.090 |
Why?
|
| Neoplasms | 1 | 2020 | 1231 | 0.080 |
Why?
|
| Calcium Channels | 1 | 2010 | 101 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 2 | 2021 | 248 | 0.080 |
Why?
|
| Intention | 1 | 2009 | 64 | 0.080 |
Why?
|
| Polyglycolic Acid | 1 | 2009 | 16 | 0.080 |
Why?
|
| Heparitin Sulfate | 1 | 2008 | 10 | 0.080 |
Why?
|
| Polysaccharide-Lyases | 1 | 2008 | 3 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2009 | 34 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 168 | 0.080 |
Why?
|
| Middle Aged | 7 | 2019 | 16314 | 0.080 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 203 | 0.080 |
Why?
|
| Pregnancy Outcome | 2 | 2021 | 181 | 0.080 |
Why?
|
| Receptors, Virus | 1 | 2008 | 67 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2009 | 71 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2011 | 814 | 0.070 |
Why?
|
| Capsid | 1 | 2008 | 88 | 0.070 |
Why?
|
| Heparin | 1 | 2008 | 111 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2010 | 486 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 868 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 527 | 0.070 |
Why?
|
| Calcium | 1 | 2010 | 555 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2009 | 391 | 0.070 |
Why?
|
| DNA, Algal | 1 | 2024 | 3 | 0.060 |
Why?
|
| Kelp | 1 | 2024 | 2 | 0.060 |
Why?
|
| Administration, Intravaginal | 1 | 2024 | 11 | 0.060 |
Why?
|
| South Carolina | 1 | 2024 | 13 | 0.060 |
Why?
|
| Chloroplasts | 1 | 2024 | 8 | 0.060 |
Why?
|
| Virginia | 1 | 2024 | 23 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2092 | 0.060 |
Why?
|
| Ectopic Gene Expression | 1 | 2023 | 1 | 0.050 |
Why?
|
| Homosexuality, Female | 1 | 2003 | 21 | 0.050 |
Why?
|
| Homosexuality, Male | 1 | 2003 | 38 | 0.050 |
Why?
|
| Cytokinesis | 1 | 2023 | 39 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2023 | 59 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 394 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2009 | 493 | 0.050 |
Why?
|
| Phylogeny | 1 | 2024 | 337 | 0.050 |
Why?
|
| Mice | 2 | 2020 | 10294 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2021 | 75 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 39 | 0.040 |
Why?
|
| Autophagosomes | 1 | 2020 | 12 | 0.040 |
Why?
|
| Mental Health | 1 | 2003 | 336 | 0.040 |
Why?
|
| Placenta Previa | 1 | 2020 | 1 | 0.040 |
Why?
|
| Cicatrix | 1 | 2021 | 59 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2020 | 34 | 0.040 |
Why?
|
| Pseudopodia | 1 | 2020 | 12 | 0.040 |
Why?
|
| Lipase | 1 | 2020 | 48 | 0.040 |
Why?
|
| Endosomes | 1 | 2021 | 170 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 226 | 0.040 |
Why?
|
| HIV | 1 | 2020 | 68 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 574 | 0.040 |
Why?
|
| Protein Transport | 1 | 2020 | 399 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2021 | 377 | 0.040 |
Why?
|
| International Cooperation | 1 | 2019 | 84 | 0.040 |
Why?
|
| Interviews as Topic | 2 | 2011 | 484 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2021 | 337 | 0.040 |
Why?
|
| Lipids | 1 | 2020 | 301 | 0.040 |
Why?
|
| Global Health | 1 | 2019 | 167 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1091 | 0.040 |
Why?
|
| Animals | 2 | 2020 | 19650 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2011 | 379 | 0.030 |
Why?
|
| Quality of Life | 1 | 2003 | 1137 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 1307 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1555 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 403 | 0.030 |
Why?
|
| Massachusetts | 1 | 2020 | 2019 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2011 | 94 | 0.020 |
Why?
|
| ORAI1 Protein | 1 | 2010 | 4 | 0.020 |
Why?
|
| Stromal Interaction Molecule 1 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2010 | 17 | 0.020 |
Why?
|
| Social Values | 1 | 2010 | 14 | 0.020 |
Why?
|
| Reproductive Medicine | 1 | 2010 | 5 | 0.020 |
Why?
|
| TRPC Cation Channels | 1 | 2010 | 11 | 0.020 |
Why?
|
| Boron Compounds | 1 | 2010 | 19 | 0.020 |
Why?
|
| Cell Size | 1 | 2010 | 40 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2010 | 126 | 0.020 |
Why?
|
| Health Surveys | 1 | 2011 | 298 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2010 | 137 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 105 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2010 | 256 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2010 | 278 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1234 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2010 | 850 | 0.010 |
Why?
|
| Wales | 1 | 2003 | 1 | 0.010 |
Why?
|
| England | 1 | 2003 | 24 | 0.010 |
Why?
|
| Prejudice | 1 | 2003 | 60 | 0.010 |
Why?
|
| Self-Injurious Behavior | 1 | 2003 | 45 | 0.010 |
Why?
|
| Social Behavior | 1 | 2003 | 87 | 0.010 |
Why?
|
| Life Style | 1 | 2003 | 299 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2003 | 288 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2003 | 687 | 0.010 |
Why?
|
| Aged | 1 | 2003 | 13406 | 0.000 |
Why?
|